Key references: Carbamazepine and oxcarbazepine poisonings

  • Albertson TE, Dawson A, de Latorre F, Hoffman RS, Hollander JE, Jaeger A, et al. TOX-ACLS: toxicologic-oriented advanced cardiac life support. Ann Emerg Med 2001;37(4 Suppl):S78–90. https://www.ncbi.nlm.nih.gov/pubmed/11290973
  • Australian and New Zealand Committee on Resuscitation. Cardiorespiratory arrest flowcharts. East Melbourne: Australian Resuscitation Council; 2016. https://resus.org.au/guidelines/flowcharts-3/
  • Brahmi N, Kouraichi N, Thabet H, Amamou M. Influence of activated charcoal on the pharmacokinetics and the clinical features of carbamazepine poisoning. Am J Emerg Med 2006;24(4):440–3. https://www.ncbi.nlm.nih.gov/pubmed/16787802
  • Dassanayake TL, Jones AL, Michie PT, Carter GL, McElduff P, Stokes BJ, et al. Risk of road traffic accidents in patients discharged following treatment for psychotropic drug overdose: a self-controlled case series study in Australia. CNS Drugs 2012;26(3):269–76. https://www.ncbi.nlm.nih.gov/pubmed/22329565
  • Dassanayake TL, Michie PT, Jones AL, Mallard T, Whyte IM, Carter GL. Cognitive skills underlying driving in patients discharged following self-poisoning with central nervous system depressant drugs. Traffic Inj Prev 2012;13(5):450–7. https://www.ncbi.nlm.nih.gov/pubmed/22931174
  • Ghannoum M, Yates C, Galvao TF, Sowinski KM, Vo TH, Coogan A, et al. Extracorporeal treatment for carbamazepine poisoning: systematic review and recommendations from the EXTRIP workgroup. Clin Toxicol (Phila) 2014;52(10):993–1004. https://www.ncbi.nlm.nih.gov/pubmed/25355482
  • Gunja N, Graudins A. Management of cardiac arrest following poisoning. Emerg Med Australas 2011;23(1):16–22. https://www.ncbi.nlm.nih.gov/pubmed/21284810
  • Hojer J, Malmlund HO, Berg A. Clinical features in 28 consecutive cases of laboratory confirmed massive poisoning with carbamazepine alone. J Toxicol Clin Toxicol 1993;31(3):449–58. https://www.ncbi.nlm.nih.gov/pubmed/8355320
  • May TW, Korn-Merker E, Rambeck B. Clinical pharmacokinetics of oxcarbazepine. Clin Pharmacokinet 2003;42(12):1023–42. https://www.ncbi.nlm.nih.gov/pubmed/12959634
  • Mortensen KE, Munkholm J, Dalhoff KP, Hoegberg LC. Oesophageal obstruction from a pharmacobezoar resulting in death. Basic Clin Pharmacol Toxicol 2017;120(2):213–6. https://www.ncbi.nlm.nih.gov/pubmed/27565635
  • Spiller HA, Krenzelok EP, Cookson E. Carbamazepine overdose: a prospective study of serum levels and toxicity. J Toxicol Clin Toxicol 1990;28(4):445–58. https://www.ncbi.nlm.nih.gov/pubmed/2269999
  • Spiller HA, Strauch J, Essing-Spiller SJ, Burns G. Thirteen years of oxcarbazepine exposures reported to US poison centers: 2000 to 2012. Hum Exp Toxicol 2016;35(10):1055–9. https://www.ncbi.nlm.nih.gov/pubmed/26612556
  • van Opstal JM, Janknegt R, Cilissen J, L’Ortije WH, Nel JE, De Heer F. Severe overdosage with the antiepileptic drug oxcarbazepine. Br J Clin Pharmacol 2004;58(3):329–31. https://www.ncbi.nlm.nih.gov/pubmed/15327594
  • Wills B, Reynolds P, Chu E, Murphy C, Cumpston K, Stromberg P, et al. Clinical outcomes in newer anticonvulsant overdose: a poison center observational study. J Med Toxicol 2014;10(3):254–60. https://www.ncbi.nlm.nih.gov/pubmed/24515527